Article
Targeting sirtuin-1 in Huntington's disease: rationale and current status.
CNS drugs - 1 May 2013
Duan Wenzhen
Abstract excerpt
Huntington's disease (HD) is an autosomal dominant hereditary disease caused by a trinucleotide repeat mutation in the huntingtin gene that results in an increased number of glutamine residues in the N terminus of huntingtin protein. Mutant huntingtin leads to progressive impairment of motor function, cognitive dysfunction, and neuropsychiatric disturbance. There are no disease-modifying treatments available....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
